Literature DB >> 19384873

Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis.

Eiji Esashi1, Hiroaki Ito, Ken-ichi Minehata, Shigeru Saito, Yoshihiro Morikawa, Atsushi Miyajima.   

Abstract

Oncostatin M (OSM) has been implicated in immune regulation, though its precise role remains elusive. Here we show that OSM plays a crucial role in the prevention of autoimmune diseases. OSM-deficient mice showed normal development of T cells, B cells and DC; however, their thymus showed hypoplasia and altered medullary structure. Autoantibodies against dsDNA accumulated and glomerulonephritis developed in aged OSM-deficient mice. Apoptotic cells accumulated in the thymus of OSM-deficient mice, and the administration of dexamethasone in young OSM-deficient mice resulted in the massive accumulation of apoptotic thymocytes and production of autoantibodies. These results suggest that OSM plays a key role in the prevention of autoimmune disease by regulating the clearance of apoptotic thymocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384873     DOI: 10.1002/eji.200839149

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

Authors:  Simon A Jones; Jürgen Scheller; Stefan Rose-John
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 2.  Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

Authors:  Krzysztof Kiryluk; Jan Novak; Ali G Gharavi
Journal:  Annu Rev Med       Date:  2012-10-16       Impact factor: 13.739

Review 3.  The genetics and immunobiology of IgA nephropathy.

Authors:  Krzysztof Kiryluk; Jan Novak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 4.  IL-27: a double agent in the IL-6 family.

Authors:  G W Jones; D G Hill; A Cardus; S A Jones
Journal:  Clin Exp Immunol       Date:  2018-03-09       Impact factor: 4.330

5.  Genome-wide association study identifies susceptibility loci for IgA nephropathy.

Authors:  Ali G Gharavi; Krzysztof Kiryluk; Murim Choi; Yifu Li; Ping Hou; Jingyuan Xie; Simone Sanna-Cherchi; Clara J Men; Bruce A Julian; Robert J Wyatt; Jan Novak; John C He; Haiyan Wang; Jicheng Lv; Li Zhu; Weiming Wang; Zhaohui Wang; Kasuhito Yasuno; Murat Gunel; Shrikant Mane; Sheila Umlauf; Irina Tikhonova; Isabel Beerman; Silvana Savoldi; Riccardo Magistroni; Gian Marco Ghiggeri; Monica Bodria; Francesca Lugani; Pietro Ravani; Claudio Ponticelli; Landino Allegri; Giuliano Boscutti; Giovanni Frasca; Alessandro Amore; Licia Peruzzi; Rosanna Coppo; Claudia Izzi; Battista Fabio Viola; Elisabetta Prati; Maurizio Salvadori; Renzo Mignani; Loreto Gesualdo; Francesca Bertinetto; Paola Mesiano; Antonio Amoroso; Francesco Scolari; Nan Chen; Hong Zhang; Richard P Lifton
Journal:  Nat Genet       Date:  2011-03-13       Impact factor: 38.330

Review 6.  Genetic studies of IgA nephropathy: what have we learned from genome-wide association studies.

Authors:  Jingyuan Xie; Samantha Shapiro; Ali Gharavi
Journal:  Contrib Nephrol       Date:  2013-05-08       Impact factor: 1.580

Review 7.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

8.  Oncostatin M decreases interleukin-1 β secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo.

Authors:  Aline Dumas; Stéphanie Lagarde; Cynthia Laflamme; Marc Pouliot
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

Review 9.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08

10.  Oncostatin M Confers Neuroprotection against Ischemic Stroke.

Authors:  Sen Guo; Zuo-Zhi Li; Jun Gong; Mei Xiang; Peng Zhang; Guang-Nian Zhao; Mingchang Li; Ankang Zheng; Xueyong Zhu; Hao Lei; Tanaka Minoru; Hongliang Li
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.